Biologics Development and Manufacturing Trends, Part 2

July 1, 2015

Article

PharmTech Multimedia

Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about biosimilar development trends.

Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about biosimilar development trends.

Related Content

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Ross Announces PFA-Coated Ribbon Blender to Be Offered for Sensitive Applications

Patrick Lavery

March 6th 2025

Article

The company said this blender supports applications for which either stainless steel or carbon steel may not be suitable.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

Developments in Aseptic Processing

Siegfried Schmitt

March 4th 2025

Article

Compliance and competitiveness are key factors in aseptic processing, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024

Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites

Patrick Lavery

February 26th 2025

Article

Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.